- Director of Digital Medicine, Assistant Professor of Cardiovascular Disease and Molecular Medicine, Scripps Research and Translational Institute.
- Serves as Regional Director of the Bluhm Cardiovascular Institute’s Clinical Trials Unit.
- Physician Entrepreneur with prior start up experience.
- Attended Stanford University, Medical School and Internal Medicine training at the University of California San Francisco
- Cardiovascular Diseases Fellowship Training at Northwestern University.
- Awarded American Heart Association Innovation Award, has completed a Device Development Fellowship and the LEAD Certificate From the Stanford School of Business.
- He has executed on multiple clinical trials and is well versed with taking an idea from zero to one and scaling to commercialization.
- President of PF Pharmaceutical Development, LLC, providing consultant services to the Pharmaceutical, Device, and Biotechnology Industries and to Venture Capital firms.
- Expertise in drug development, regulatory strategy, and translational science.
- Formerly Senior Director, vice-president, and CMO in large and small pharmaceutical companies, including Merck Research Laboratories, Bayer Pharmaceuticals, Karos Pharmaceuticals.
- Led large clinical programs for new antihypertensive and antidiabetic drugs development; mentored strong clinical teams; worked closely with basic science and commercial teams; headed company safety boards.
- Developed multiple cardiovascular, metabolic, and other compounds and achieved regulatory approval worldwide of three new molecular entities.
- Maintains an academic career as Clinical Associate Professor of Medicine at Weill Cornell Medical College where he is also a consultant to the Clinical Translational Science Center, developing courses in translational science and, until recently, attending physician at the Yale-affiliated VA Medical Center.